Description
Indication & Scope
NaXinDe® Tenofovir Disoproxil Fumarate Tablets provides nucleoside reverse transcriptase inhibitor for antiviral management of chronic hepatitis B; combined regimen therapy for HIV‑1 infection.
- Mechanism: After intracellular phosphorylation, active metabolite obstructs viral reverse transcriptase, terminates viral DNA chain elongation and suppresses virus replication.
- Drug class: Nucleoside reverse transcriptase inhibitor, antiviral agent.
- Clinical use: Antiviral treatment for chronic hepatitis B; combination antiretroviral therapy for HIV‑1 infection.
| Generic Name | Tenofovir Disoproxil Fumarate Tablets |
| Brand Name | NaXinDe® |
| Ingredient | Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablets |
| Package | 0.3g*30 tablets/box |
| Conditions Treated | Chronic hepatitis B virus infection, HIV‑1 infection (combined scheme) |
| Taboos | Hypersensitivity against tenofovir disoproxil fumarate or excipients of this tablet |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Seal, store at room temperature, keep dry |
| Manufacturer | Qilu Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20173185 |
| Approval Date | Dec 24, 2021 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: One tablet once daily for adults.
Time: May be taken with or without food.
Instructions for use: Swallow whole tablet; do not discontinue arbitrarily. Regular monitoring of viral load, liver and renal function is required.
Interaction: Co‑administration with other nephrotoxic drugs increases renal injury risk; adjust dosage under renal impairment.
Side effects: Mild gastrointestinal symptoms are common. Long‑term therapy may bring renal function decline and bone mineral‑density reduction.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What two major infectious diseases can Tenofovir Disoproxil Fumarate Tablets be applied to treat?
It treats chronic hepatitis B, and participates in combined regimen for HIV‑1 infection therapy.
What two organ‑related safety indicators need long‑period surveillance during medication of Tenofovir Disoproxil Fumarate Tablets?
Renal function and bone mineral density should be tracked for long‑term treatment population.
Is random self‑discontinuation permitted after improvement of liver‑related laboratory indexes when using Tenofovir Disoproxil Fumarate Tablets?
Arbitrary discontinuation is forbidden, which may result in hepatitis‑condition rebound or exacerbation.
How does food influence oral absorption efficiency of Tenofovir Disoproxil Fumarate Tablets?
Administration can be implemented either with meals or on an empty stomach.
NaXinDe® | Tenofovir Disoproxil Fumarate Tablets | HBV/HIV-1 | DengYueRX
INN: Tenofovir Disoproxil Fumarate Tablets
Indications: HBV/HIV-1
Dosage Form: Tablets
Strength: 0.3g/tablet
Original price was: $2.17.$1.84Current price is: $1.84.
